Gossamer Bio Inc’s filing revealed that its Director Milligan Sandra acquired Company’s shares for reported $50016.0 on Aug 19 ’25. In the deal valued at $1.92 per share,26,050 shares were bought. As a result of this transaction, Milligan Sandra now holds 58,050 shares worth roughly $0.13 million.
UBS upgraded its Gossamer Bio Inc [GOSS] rating to a Buy from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in mid July with a ‘”a Sector outperform”‘ rating. Oppenheimer began covering GOSS with “an Outperform” recommendation on June 25, 2024.
Price Performance Review of GOSS
On Tuesday, Gossamer Bio Inc [NASDAQ:GOSS] saw its stock fall -3.77% to $2.3. Over the last five days, the stock has lost -3.36%. Gossamer Bio Inc shares have risen nearly 161.96% since the year began. Nevertheless, the stocks have risen 154.26% over the past one year. While a 52-week high of $3.60 was reached on 09/12/25, a 52-week low of $0.66 was recorded on 04/09/25.
Levels Of Support And Resistance For GOSS Stock
The 24-hour chart illustrates a support level at 2.26, which if violated will result in even more drops to 2.23. On the upside, there is a resistance level at 2.35. A further resistance level may holdings at 2.41.
How much short interest is there in Gossamer Bio Inc?
A steep rise in short interest was recorded in Gossamer Bio Inc stocks on 2025-10-15, growing by 2.77 million shares to a total of 26.76 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 23.99 million shares. There was a rise of 10.34%, which implies that there is a positive sentiment for the stock.
